Purchases and Sales Made in Q3 2022 in Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB) during Q3 2022. The information is specifically focused on institutions that hold shares of PharmaCyte Biotech, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 09, 2022
Q3 2022
|
Ayrton Capital LLC
Westport, CT |
BUY
|
- |
880K+ 574.68% |
$1.97M - $2.51M
|
1.03M
$1.62M
|
|
|
Nov 14, 2022
Q3 2022
|
K2 Principal Fund, L.P.
Toronto, A6 |
BUY
|
- |
520K+ 570.91% |
$1.16M - $1.48M
|
611K
$960K
|
|
|
Oct 04, 2022
Q3 2022
|
Csenge Advisory Group
|
BUY
|
- |
200KNew |
$448K - $570K
|
200K
$314K
|
|
|
Oct 26, 2022
Q3 2022
|
Iq Eq Fund Management (Ireland) LTD
|
BUY
|
- |
38.8KNew |
$86.8K - $110K
|
38.8K
$60.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Shay Capital LLC
New York, NY |
BUY
|
- |
33K+ 3.35% |
$73.8K - $94K
|
1.02M
$1.59M
|
|
|
Nov 04, 2022
Q3 2022
|
Simplex Trading, LLC
|
BUY
|
- |
10.5K+ 19.1% |
$23.5K - $29.9K
|
65.4K
$103K
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
7.5K+ 42.8% |
$16.8K - $21.4K
|
25K
$39.3K
|
|
|
Nov 09, 2022
Q3 2022
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
6.01K+ 8.71% |
$13.5K - $17.1K
|
75.1K
$118K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
2.27K+ 25.53% |
$5.08K - $6.46K
|
11.1K
$17.5K
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
800+ 0.12% |
$1.79K - $2.28K
|
643K
$1.01M
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
53+ 54.08% |
$119 - $151
|
151
$237
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1- 0.72% |
$2.24 - $2.85
|
138
$217
|
|
|
Jul 17, 2024
Q3 2022
|
Kelly Financial Services LLC
Braintree, MA |
SELL
|
- |
-28- 10.69% |
$62.7 - $79.8
|
234
$367
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.06K- 91.65% |
$2.38K - $3.03K
|
97
$152
|
|
|
Nov 14, 2022
Q3 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-1.4K- 5.34% |
$3.14K - $3.99K
|
24.8K
$38.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-1.68K- 96.89% |
$3.76K - $4.79K
|
54
$84.8
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.5K- 98.77% |
$5.59K - $7.11K
|
31
$48.7
|
|
|
Oct 11, 2022
Q3 2022
|
Equitec Proprietary Markets, LLC
|
SELL
|
- |
-12.3K- 3.59% |
$27.6K - $35.1K
|
331K
$519K
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-15K- 24.19% |
$33.6K - $42.8K
|
47K
$73.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-34.8KClosed |
$78K - $99.2K
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-62K- 78.85% |
$139K - $177K
|
16.6K
$26.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-494K- 46.52% |
$1.11M - $1.41M
|
568K
$891K
|